Recombinant Mycobacterium Tuberculosis Fusion Protein（EC）Instructions for Use

Update: 31 October, 2023

Recombinant Mycobacterium Tuberculosis Fusion Protein（EC）is indicated for the diagnosis of tuberculosis infection. It is recommended for use in infants aged 6 months and above, children and adults under 65 years of age. This product's skin test results are not affected by BCG vaccination, and can be used to assist in the clinical diagnosis of tuberculosis.

---

File format: PDF

Size: -

MD5 Checksum: 4660DE624C609D469786FE5966268D49

Publication date: 31 October, 2023

Downloads: -

PDF Link: Recombinant Mycobacterium Tuberculosis Fusion Protein（EC）Instructions for Use PDF